Add BrightSurf on Google Email

American Society for Microbiology


Bug vs. bug: Benign C. difficile strains keep fatal strains at bay

Researchers found that two benign strains of C. difficile can prevent infection by more dangerous strains. The harmless strains occupy the same niches as the infective strains, preventing colonization and ultimately infection. This study provides promising results for developing new protective measures against C. difficile infection.

SourceAmerican Society for Microbiology·JournalAntimicrobial Agents and Chemotherapy·DateOct 2, 2013

HIV-derived antibacterial shows promise against drug-resistant bacteria

Researchers have developed HIV-derived antibacterial compounds that target and disrupt bacterial membranes, showing powerful activity against clinically resistant bacteria. These engineered cationic antimicrobial peptides (eCAPs) may also be applicable to treatment of other respiratory infections and biodefense applications.

SourceAmerican Society for Microbiology·JournalAntimicrobial Agents and Chemotherapy·DateJun 19, 2013